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PLASMA ADP L E V E L S :  DIRECT D E T E M I N A -  
TION W I T H  L U C I F E R A S E  L U M I N E S C E N C E  
USING A BIOMETER 
A method is described for  the determinat ion of 
low plasma levels of adenosine-5'-diphosphate 
(ADP)  using a Dupont Biometer to measure lumi- 
nescence produced by the luciferin-luciferase reac- 
tion. Endogenous ATP is removed by incubation 
with luciferase. The remaining ADP is then quan- 
t i tated,  following its conversion to ATP,  a f te r  in- 
cubation with creatine phosphate and creatine 
kinase. The mean coefficient of var ia t ion for 0.02 
and 2 2 ~mol/ l i ter  ADP s tandards  were 2.1 and 1.8% 
respectively. The method has been applied to human 
and rabbi t  plasma. Human plasma ADP concen- 
t ra t ions  were found to be 0.13 --  0.025 (10) l~mol/ 
l i ter  and rabbi t  p lasma concentration were 0.07 ± 
0.05 (5) btmol/liter. Several other possible applica- 
tions of the method are discussed. 
EVIDENCE OBTAINED IN RECENT YEARS SUPPORTS THE 
INVOLVEMENT Of adenos ine  5 ' d iphospha t e  ( A D P )  in 
the  m e c h a n i s m  of  p l a t e l e t  a g g r e g a t i o n .  T h r o m b o -  
cy tes  can d i r ec t l y  be a g g r e g a t e d  in v i t ro  by  A D P  ~5~ 
and  m a n y  be l i eve  p l a t e l e t  a g g r e g a t i o n  is  m e d i a t e d  
t h r o u g h  i n d u c e d  p l a t e l e t  A D P  r e l e a s e  ~'' 9.,~. W h e n  
b lood  was  p a s s e d  t h r o u g h  a g l a s s  b e a d  c o l u m n  
p l a t e l e t  r e t e n t i o n  o c c u r r e d .  Th i s  was  a t t r i b u t e d  to  
t h e  i n d u c e d  A D P  r e l e a s e  f r o m  the  r ed  ce l l s  a n d  a 
c o r r e l a t i o n  e x i s t e d  b e t w e e n  p l a t e l e t  r e t e n t i o n  and  
the  a m o u n t  of  h e m o g l o b i n  c o n c e n t r a t i o n  in t h e  
p l a s m #  2°~. P l a s m a  A D P  leve l s  m a y  p o s s i b l y  i n c r e a s e  
in s t o r e d  b lood,  o r  k i d n e y  d i a l y z e r s  and  l u n g  oxy-  
g e n a t o r s ,  d u e  to r ed  cel l  m e m b r a n e  r u p t u r e .  Th i s  
cou ld  become  a d a n g e r o u s  s o u r c e  to  embo l i c  p r o b -  
lems.  B a n k e d  b lood  w a s  shown  to c o n t a i n  an  a v e r a g e  
o f  100 a g g r e g a t e s  p e r  mm c3~, r a n g i n g  f r o m  10 to 200 
in d i a m e t e r  c24~ and  e x t r a c o r p o r e a l  c i r c u l a t i o n  w a s  
s lmwn to have  a h igh  o c c u r r e n c e  of  p o s t - o p e r a t i v e  
c o m p l i c a t i o n s  i n v o l v i n g  v i t a l  o r g a n #  ~'4'8~. P l a t e l e t  
a g g r e g a t i o n  r e s u l t i n g  in e x t e n s i v e  v a s c u l a r  b lock-  
age  was  d e m o n s t r a t e d  in e n d o t o x i n  "9~. The  a c c u m u -  
l a t i o n  of  h igh  p l a s m a  A D P  leve ls  cou ld  have  occur -  
r e d  due  to t h e  d e c r e a s e d  m e t a b o l i c  s t a t e  in  shock  
, i ,  18.~, and  these  leve ls  m a y  have  been  s i g n i f i c a n t  
in t he  p l a t e l e t  a g g r e g a t i o n  a n d  v a s c u l a r  b lockage .  
B e c a u s e  of  the  i m p o r t a n c e  shown  A D P  as a p l a t e l e t  
a g g r e g a t o r  we f e l t  i t  a p p r o p r i a t e  to  deve lop  a p ro -  
cedure  w h e r e b y  tzmolar  p l a s m a  A D P  concen t r a t i ons  
could be ana lyzed  rou t ine ly .  
C u r r e n t  m e t h o d s  f o r  m e a s u r i n g  low leve ls  of  
A D P  do so by  f i r s t  m e a s u r i n g  A T P  then  e n z y m a -  
t i c a l l y  c o n v e r t i n g  A D P  to A T P  a n d  r e d e t e r m i n i n g  
ATP,0 .  m. The  A D P  c o n c e n t r a t i o n s  a r e  t hen  ca l -  
c u l a t e d  by  d i f f e r e n c e .  S ince  n o r m a l  h u m a n  p l a s m a  
u s u a l l y  has  a r e l a t i v e l y  h i g h  A T P  c o n t e n t  (2 tzmol /  
l i t e r )  "~  a low p l a s m a  A D P  c o n t e n t  cou ld  be  d i f f i -  
cu l t  to a s sess .  We t h e r e f o r e ,  w a n t e d  a s e n s i t i v e  
m e t h o d  w h i c h  w o u l d  d i r e c t l y  m e a s u r e  p l a s m a  A D P .  
We chose ,  as  have  o t h e r s , " '  ~o, 13-15. 23) t he  f i r e f l y  luc i -  
f e r a s e  enzyme  s y s t e m  fo r  m e a s u r i n g  A T P .  The  lumi -  
n e s c e n c e  was  m e a s u r e d  u s i n g  a D u p o n t  BiometerC*L 
E n d o g e n o u s  A T P  was  f i r s t  r e m o v e d  f r o m  t h e  p l a s -  
m a  s a m p l e s  fo l l owed  by  c o n v e r s i o n  of  A D P  to A T P  
wi th  a c r e a t i n e  k i n a s e  (EC 2.7.3.2) sys t em.  
METHODS 
Extraction procedures. 
About 3 ml of venous blood is sampled into a tube 
to a final  ant i -coagulant  concentration of about 10 mmol/  
l i ter  disodium ethylendiaminete t race ta te  per  l i ter.  An 
EDTA concentration of 5 retool / l i ter  has been shown to 
tota l ly  inhibit  the breakdown of adenine nucleotides in 
plasma "°J as well as prevent ing coagulation. The whole 
blood was centr ifuged at  2000 x g for  2 rain. To the p lasma 
layer  was added an equal volume of e thanol /water  (96/ 
4 by vol) thus denatur ing all enzymes present  "°~. The 
solution was then centr ifuged at  12000 x g and the re- 
sulting supernate  was stored in the re f r ige ra to r  a t  4°C 
for subsequent analysis.  
Luminescence Determinations. 
Luciferin luciferase luminescence was determined with 
a DuPont 760 Luminescence Biometer c3) using DuPont 
Reagent  kits.  A 10 ~1 aliquot of sample or s tandard  was 
injected into 100 ~1 of luciferase reaction mixture  by 
means of a springloaded syringe (Shandon ReporJector) .  
The Biometer digi tal  readout  was taken a f te r  a period 
of time. The reaction mixture contained the following: 
MgS04, 10 mmol / l i t e r :  morpbolinopropane sulfonic acid 
buffer ,  10 mmol/ l i ter ,  pH 7.4: crystal l ine luciferin,  0.71 
retool/ l i ter  and 100 U of crystal l ine f i re f ly  luciferase. 
The reaction mixture  was placed in a Biometer cuvette 
which was placed in f ront  of the photomult ipl ier  tube 
inside the instrument.  The Biometer can be adjusted so 
tha t  the digi tal  readout  corresponds to the concentration 
of ATP,  or one can construct  a s tandard  curve. All s tand-  
ard ATP solutions contained an equal volume of e thanol /  
water.  (96/4 by vol). Ethanol does not in ter fere  with 
the l ight  reaction. 











Fig. 1 - -  Time course of endogenous plasma A T P  levels 
following incubation with luciferin-luei/erase. The curves 
represent 2 ~mol/liter and 8 ~mol/liter plasma A T P  /or 
a and b respectively. 
ADP Determinations 
In order to utilize the luciferase luminescence for  the 
direct determination of ADP it was f i rs t  necessary to 
remove any endogenous ATP. 
In a previous C'~ paper we accomplished this by incu- 
bation of the plasma extracts with apyrase (EC 3.6.1.2), 
a nuclease from potato. For  the present experiments 
apyrase could not be used because it also hydrolyzes ADP. 
However, use was made of the specificity of the luciferin 
luciferase reaction. I t  has been established ~ that  the 
reaction is specific for ATP and that  the product is 
AMP. Thus, endogenous ATP was eliminated by incubat- 
ing the plasma extracts with a luciferin-luciferase mixture 
in an arsenate-magnesium chloride buffer  cu~ at 25°C. 
The extent of hydrolysis was followed by reading the 
luminescence in the Biometer, and the time necessary 
for the complete removal of ATP was determined. 
As reported earlier ~m the highest amount of plasma 
ATP found was in the ra t  (8.09 ~mol/ l i ter) ,  whereas for 
rabbits and humans the value is about 2 ~mol/liter.  
Thus 8 ~mol/ l i ter  ATP was taken as a maximum ATP 
quanti ty for  removal in experiments involving rats  and 
2 ~mol/ l i ter  as the removable quanti ty when investigat- 
ing human or rabbit plasma. The actual amount used 
in the experimental standards was 4 and 1 ~mol-liter 
ATP respectively because of the dilution with ethanol. 
Into 100 ~l of arsenate buffered luciferin-luciferase was 
injucted 10 of 4 ~l and 1 ~mol/ l i ter  ATP  and the lumines- 
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Fig. 2 - -  Au~oradiogram of separated products follow- 
ing incubation of 14C-ATP and ~4~ A D P  with luciferin- 
luciferase. A and B are ~4C-ATP and ~4C-ADP respec- 
tively incubated with bullet .  C and D are the products 
after incubation with lueiferin-luciferase. 
30 minute incubation period is needed for the complete 
removal of 4 ~mol/l i ter  ATP while the elimination of 
1 ~mol/l i ter  ATP required only 5 minutes. 
We verified the specificity of the reaction using radio- 
labled ADP and ATP (New England Nuclear, Boston, 
MA). Ten ~I of radioactive ADP and ATP (2000 DPM 
of each) were mixed separately in 100 ~1 of arsenate 
buffered control and 100~1 of the arsenate buffered 
luciferinluciferase mixture. Af ter  a reaction time of 
20 minutes all four samples were spotted on a poly- 
ethyleneimine thin layer plate and separated as 
described by others ~16~. The plates were dried and 
laid over No-Screen Xray film for 48 hours. Af-  
ter the film was developed the results given in Fig. 2 
were obtained. The A T P  mixed with the luciferin luci- 
/erase (D) showed complete reaction to AMP with no 
apparent  ATP remaining in the vicinity of the standard 
ATP (A). Also in D there was no detection of any prod- 
ucts in the vicinity of the standard ADP position (B). 
The proximity of the spot in D most likely refers to 
AMP in accordance with previous results c16~. From the 
results in C, ADP showed no reaction with the luciferin- 
luciferase mixture. Af te r  the removal of ATP the plasma 
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Fig. 3 - -  E//ee~ o/ ereatine phosphokinase (CK) levels 
on luminescence. 
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Fig. ~ - -  E / fee t  o~ creatine phosphate concentrations on 
luminescence. 
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TABLE 1 
STABILITY OF AmP IN T W O  SAMPLES OF HUMAN PLASIvlA 
TABLE 2 
HUMAN AND RABBIT PLASMA ADP LEVELS. 
Standing Conc. ~ mol/li ter 
Time (Min) A B 
o 2.0 1.96 
6 2.0 1.95 
11 1.97 1.95 
15 1.97 1.93 
60 1.95 1.90 
Crea t ine  Phosphate  + A D P  ~ Crea t ine  -{- A T P  
The resu l t ing  A T P  being measured  in the Biometer.  The 
amount  of creat ine kinase (CK) necessary to quant i ta -  
t ively  conver t  the measurable  A D P  at  the expense of a 
f ixed amount  of creat ine  phosphate  (CP) was determined.  
The max imum concentra t ion of CP was a rb i t r a r i l y  chosen 
as 30 ~mol / l i t e r .  Since 2 ~mol / l i t e r  A D P  was previous ly  
shown to me the cri t ical  concentra t ion  fo r  p la te le t  agg rega -  
t ion and release ~'~), this  amount  was set  as the max imum 
plasma concentra t ion expected. The actual  concentra t ion 
analysed was only 1 ~mol / l i t e r  since the samples are  
diluted with  96% ethanol.  S t reh le r ' s  a r sena te -magnes ium 
chloride bu f f e r  system '24) was used due to CK inhibit ion 
by sulfate .  The procedure  for  the de terminat ion  of the 
min imum units  of CK needed for  the assay was as fol- 
lows;  direct ly  into each cuvet te  conta in ing 100 ~tl of the 
luc i fer in- luc i ferase  mix tu re  was added 10 ~l of 30~mol/  
l i ter  CP and 10 ~1 of 1 ~mol / l i t e r  A D P  solution in 5 
mmol / l i t e r  Na2EDTA and 48% ethanol.  Each cuvette  
was then placed, in turn ,  in f ron t  of the Biometer  photo- 
mul t ip l ie r  tube and a 10 ~l CK solution injected. The 
amount  of enzyme in the solutions var ied  f rom 26 k U /  
l i ter  to 1680 k U / l i t e r .  The digi ta l  r eadout  was recorded 
a f t e r  40 seconds a t  a course sensi t iv i ty  se t t ing  of 6. The 
resul ts  a re  given in Fig.  3. F r o m  this curve  the enzyme 
solution conta in ing 560 k U / l i t e r  of CK was chosen. 
The concentra t ion of CP necessary  for  opt imum reac- 
tion with  1 ~mol / l i t e r  A D P  solution was determined.  
Va ry ing  amounts  of CP, f rom 0.29 to 290 ~mol / l i t e r  were  
added to the b iometer  cuvettes.  The procedure  was the 
same as before  and 560 k U / l i t e r  of CK was injected in 
each case. Fig.  4 shows tha t  the min imum CP concen- 
t ra t ion  to give a max imum react ion ra te  was wi th  a 70 
~mol / l i t e r  solution. 
Us ing  the opt imal  conditions of CK and CP var ious  
amounts  of A D P  were analysed over  an 80 second period 
of time. All A D P  s tandards  contained 4 ~molar  A T P  in 
48% ethanol  and 5 ~molar  EDTA.  Ten al of  each 
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Fig. 5 - -  Ef fect  of time of reading the Biometer after 
injecting the sample for determining ADP. ADP con- 
centrations (~mol/liter) were: a, 0.02; b, 0.10; C, 0.21; 
d, 1.0~; c, 2.08. 
ADP Source _ _  ~ mol/li ter ADP 
Norma lHuman  . . . . . . . . . . . . .  0.130 ± 0.025 (10) 
Normal Rabbit  . . . . . . . . . . . . . .  0.07 -4- 0.05 (5) 
Rabbit  in Endotoxin Shock. . .  0.26 + 0.13 (5) 
into the 100 ~I of a r sena te  buf fe red  luc i fe r in- luc i fe rase  
followed by a 30 minute  incubation period a t  25°C. Then 
10 ~l of CK (560 k U / l i t e r )  was sp r ing  injected into the  
cuvet te  and the Biometer  read ing  taken,  a t  a sens i t iv i ty  of 
6, a t  var ious  times. The resul ts  a re  given in Fig.  5. The 
readout  t ime chosen for  A D P  quant i ta t ion  was 40 seconds, 
which allows adequate  t ime for  the react ion to equi l ibrate .  
Fig.  6 is an A~DP s t andard  curce, over  a concentra t ion 
span of 100 fold, us ing the 40 second time. 
A D P  Stabil i ty.  
The s tabi l i ty  of A D P  in human plasma fol lowing the 
ini t ial  cen t r i fuga t ion  was assessed. Because of the nor-  
mal ly  low A D P  levels each sample was made to a theoret-  
ical A D P  concentra t ion of 2 ~mol / l i t e r  us ing a s t andard  
A D P  solution. Two samples of human p lasma were  al- 
lowed to stand, a t  room tempera tu re ,  and aliquots were  
ex t rac ted  and the A D P  levels de termined at  the var ious  
t ime in terva ls  shown in Table 1. 
As can be seen there  was essent ia l ly  complete A, DP  
re tent ion over  a 60 minute  s tand ing  period. 
RESULTS AND DISCUSSION 
T h e  m e t h o d  as  d e s c r i b e d  is such  t h a t  t h e  m e a s u r e -  
m e n t s  can  be m a d e  of  A D P  levels  o v e r  a w i d e  r a n g e  
o f  c o n c e n t r a t i o n s .  I n  t h i s  p a p e r  we  used  a c o n c e n t r a -  
t ion  span  of  100 fold,  t h e  l i n e a r i t y  o f  w h i c h  is seen  
in F i g .  6. D a y  to day  p r e c i s i o n  w a s  e v a l u a t e d  u s i n g  
t h r e e  d e t e r m i n a t i o n s  o f  each  s t a n d a r d ,  r a n g i n g  f r o m  
0.02 to 2 / z m o l / l i t e r ,  e v e r y  day  t h e  B i o m e t e r  w a s  
used.  T h e  ove ra l l  a v e r a g e  o f  t h e  m e a n  c o e f f i c i e n t  
o f  v a r i a t i o n s  f o r  all  a s s a y s  was  1 .75%.  T h e  p r e c i s i o n  
o f  a s i n g l e  s a m p l e  was  a s se s sed  by e x t r a c t i n g  t w o  con-  
t ro l  se ra ,  w i t h  a d j u s t e d  A D P  levels ,  20 t i m e s  a n d  
m e a s u r i n g  t h e  l u m i n e s c e n c e  in t h e  usua l  m a n n e r .  T h e  
m e a n  c o e f f i c i e n t  o f  v a r i a t i o n  f o r  0.02 and  2 / z m o l /  
l i t e r  A D P  w e r e  2.1 and  1 .8% r e s p e c t i v e l y .  
W e  h a v e  app l i ed  t h e  m e t h o d  to h u m a n  and  r a b b i t  
p l a sma .  T h e  h u m a n  s a m p l e s  w e r e  o b t a i n e d  f r o m  
8" 
g 
~6-  ..J 
192 
A D P concn , - -Log  mo~liter 
Fig. 6 - -  Typical ADP standard curve. 
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laboratory technicians. Rabbit samples were obtained 
from normal rabbits before and at death due to E. 
coli enduced endotoxin shock. These results are given 
in Table 2. The plasma ADP levels of the rabbits in 
endotoxin shock increased almost 4 fold, however, 
they never reached the 1 to 2 /zmol/liter concentra- 
tion shown necessary to aggregate platelets in vitro 
using platelet rich plasma ~2~. We do not immediately 
know the explanation for this but the phenomenon 
is currently under investigation. 
Additional applications of the present method are 
also feasible. In atherosclerosis the vessel walls nar- 
row until total occlusion results and individuals who 
have this problem usually die of strokes or coronaries, 
because of eventual thrombotic complications. Ele- 
vated ADP plasma levels in these patients could 
be a causative factor leading to platelet wall deposits 
instigating the narrowing process. Atherosclerotics 
are extremely sensitive to ADP as shown by the fact 
that  ADP concentrations which normally cause only 
a pr imary aggregation in normal individuals cause a 
high primary wave or secondary wave in these pa- 
tients 'zT'. I t  could prove beneficial to monitor the 
plasma ADP levels in these patients. The ADP con- 
tent of stored blood should possibly be periodically 
checked before being used in transfusions because of 
possibly high ADP levels which may develop during 
storage and be detrimental to the recipients. The in- 
creasing use of artificial systems to replace impaired 
organs, e.g., dialyzers for kidneys or oxygenators 
for lungs were shown to become impeded by ad- 
hering aggregates of platelets (~'. However, the reason 
for occurrence has not been definitely determined 
Should hemolysis occur in these procedures, because 
of the mechanical shear on the red cells, one would 
have to be suspicious of the ADP level of the per- 
fused blood. In open heart  surgery, accompanied by 
cardiopulmonary bypass, periodic sampling of blood 
levels of ATP, ADP and CP from the heart  pump 
oxygenator may give an indication of the metabolic 
cellular condition of the patient. 
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